Bio-Works Technologies AB has announced the launch of WorkBeads affimAb, a novel affinity chromatography resin designed for the purification of next-generation biological pharmaceuticals. The product targets the growing market for bispecific antibodies and other advanced therapeutics, offering high binding capacity and selectivity.